Growth hormone deficiency, aortic dilation, and neurocognitive issues in Feingold syndrome 2.
Michael MurielloAlexander Y KimKrista Sondergaard SchatzNatalie BeckMeral Gunay-AygunJulie Elizabeth Hoover-FongPublished in: American journal of medical genetics. Part A (2019)
We report three patients with Feingold 2 syndrome with the novel features of growth hormone deficiency associated with adenohypophyseal compression, aortic dilation, phalangeal joint contractures, memory, and sleep problems in addition to the typical features of microcephaly, brachymesophalangy, toe syndactyly, short stature, and cardiac anomalies. Microdeletions of chromosome 13q that include the MIR17HG gene were found in all three. One of the patients was treated successfully with growth hormone. In addition to expanding the phenotype of Feingold 2 syndrome, we suggest management of patients with Feingold 2 syndrome include echocardiography at the time of diagnosis in all patients and consideration of evaluation for growth hormone deficiency in patients with short stature.
Keyphrases
- growth hormone
- end stage renal disease
- left ventricular
- newly diagnosed
- chronic kidney disease
- ejection fraction
- case report
- mental health
- cell proliferation
- computed tomography
- copy number
- physical activity
- aortic valve
- zika virus
- patient reported outcomes
- dna methylation
- gene expression
- working memory
- genome wide
- transcription factor
- autism spectrum disorder
- long non coding rna
- bipolar disorder
- pulmonary hypertension
- coronary artery
- patient reported
- atrial fibrillation
- living cells